ArticleDiabetes technology & therapeutics2024
Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes.
Open access · hybridAbstract readMulticenter Study
In one paragraph
Article in Diabetes technology & therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 34 citations in OpenAlex.
- Extended Use of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 1 Diabetes: 12-Month Extension of a Randomized Controlled Trial.Endocrinology, diabetes & metabolism · 2026Trial
- Psychosocial outcomes among adults with type 1 diabetes using a tubeless automated insulin delivery system compared with sensor augmented pump therapy: A randomised, parallel-group clinical trial sub-study.Diabetes, obesity & metabolism · 2026Trial
- Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trial.Frontiers in endocrinology · 2025Trial
- Trial
- Looking Beyond Glycaemic Control: Real-World 12-Month Cardiometabolic and Retinopathy Outcomes Following Omnipod 5 Initiation in People With Type 1 Diabetes.Diabetes, obesity & metabolism · 2026Article
- Artificial Pancreas and Closed-Loop Insulin Delivery: From Early Concepts to AI-Driven Diabetes Automation.Biosensors · 2026Review
- Long-term effectiveness of automated insulin delivery in young people with type 1 diabetes: a meta-analysis.Diabetology & metabolic syndrome · 2026Article
- Transitioning to Omnipod 5Biomedicines · 2026Article
- Inpatient Use of Automated Insulin Delivery Systems.Journal of diabetes science and technology · 2026Review
- Numeracy Skills and Glycemic Control in an Observational, Multicenter, Cross-Sectional, and International Study of Children with Type 1 Diabetes.Hormone research in paediatrics · 2026Observational
- Impact of Automated Insulin Delivery Systems in Children and Adolescents with Type 1 Diabetes Previously Treated with Multiple Daily Injections: A Single-Center Real-World Study.Medicina (Kaunas, Lithuania) · 2025Observational
- Ethnicity and socioeconomic status do not influence glycaemic outcomes of a tubeless hybrid closed-loop system (Omnipod® 5) in adults with type 1 diabetes.Diabetes, obesity & metabolism · 2025Observational
- Omnipod 5 in children and adolescents with type 1 diabetes: Improved outcomes with fewer boluses.Diabetes, obesity & metabolism · 2025Article
- Registration and Real-Life Studies on Automated Insulin Delivery Systems.Journal of diabetes science and technology · 2025Review
- Safety, efficacy and psychological impact of Omnipod hybrid closed loop system in children, adolescents, and adults in 24 h and nighttime: Systematic review with additional meta-analysis.Journal of diabetes and metabolic disorders · 2025Review
- Does the OP5 Automated Insulin Delivery System Close the Gap in Glycemic Control Between White and Black Youth with Type 1 Diabetes?Diabetes technology & therapeutics · 2025Article
- Closed-loop therapy: recent advancements and potential predictors of glycemic outcomes.Expert opinion on drug delivery · 2025Review
- Real-world glycemic outcomes of a tubeless automated insulin delivery system: a single-center observational study in Italy.Frontiers in endocrinology · 2025Observational
- Assessing the iLet Bionic Pancreas Deployed in Primary Care and via Telehealth: A Randomized Clinical Trial.Clinical diabetes : a publication of the American Diabetes Association · 2025Article
- Enhancing equity in access to automated insulin delivery systems in an ethnically and socioeconomically diverse group of children with type 1 diabetes.BMJ open diabetes research & care · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors at 16 institutions in 1 country.
Amy B CriegoDepartment of Pediatric Endocrinology, International Diabetes Center, Park Nicollet, Minneapolis, Minnesota, USA.
Anders L CarlsonInternational Diabetes Center, Park Nicollet, HealthPartners, Minneapolis, Minnesota, USA.
Sue A BrownDivision of Endocrinology, Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
Gregory P ForlenzaDepartment of Pediatrics, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.ORCID 0000-0003-3607-9788
Bruce W BodeAtlanta Diabetes Associates, Atlanta, Georgia, USA.
Carol J LevyDivision of Endocrinology, Diabetes, and Metabolism, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
David W HansenDepartment of Pediatrics, SUNY Upstate Medical University, Syracuse, New York, USA.
Irl B HirschDepartment of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-1675-8417
Richard M BergenstalInternational Diabetes Center, Park Nicollet, HealthPartners, Minneapolis, Minnesota, USA.ORCID 0000-0002-9050-5584
Jennifer L SherrDepartment of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0001-9301-3043
Sanjeev N MehtaJoslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA.
Lori M LaffelJoslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-9675-3001
Viral N ShahDepartment of Pediatrics, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.ORCID 0000-0002-3827-7107
Anuj BhargavaIowa Diabetes Research, West Des Moines, Iowa, USA.
Ruth S WeinstockDepartment of Medicine, SUNY Upstate Medical University, Syracuse, New York, USA.ORCID 0000-0001-5859-5666
Sarah A MacLeishDepartment of Pediatrics, University Hospitals Cleveland Medical Center, Rainbow Babies and Children's Hospital, Cleveland, Ohio, USA.
Daniel J DeSalvoDepartment of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0002-0440-3339
Thomas C JonesDepartment of Research, East Coast Institute for Research at The Jones Center, Macon, Georgia, USA.
Grazia AleppoDivision of Endocrinology, Metabolism, and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Bruce A BuckinghamDivision of Pediatric Endocrinology, Department of Pediatrics, Stanford University, Stanford, California, USA.
Trang T LyInsulet Corporation, Acton, Massachusetts, USA.ORCID 0000-0002-5995-1447
Park Nicollet Clinic · USJoslin Diabetes Center · USSUNY Upstate Medical University · USUniversity of Colorado Anschutz Medical Campus · USAtlanta Diabetes Associates · USBaylor College of Medicine · USIcahn School of Medicine at Mount Sinai · USInsulet (United States) · USIowa Diabetes and Endocrinology Research Center · USJones Institute · USNorthwestern University · USRainbow Babies & Children's Hospital · USStanford Medicine · USUniversity of Virginia · USUniversity of Washington · USYale University · US
Funding
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9MSPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5MNCATS NIH HHS UL1 TR001863NIDDK NIH HHS P30 DK036836
Abstract
PubMed holds no abstract for this paper.
Indexed as
Diabetes Mellitus, Type 1AdolescentAdultBlood GlucoseBlood Glucose Self-MonitoringChildGlycated HemoglobinHumansHypoglycemic AgentsInsulinInsulin Infusion SystemsBlood GlucoseGlycated HemoglobinHypoglycemic AgentsInsulinArtificial pancreasClinical trialsClosed-loop systemsInsulin pumpsType 1 diabetes
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.